TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 101 filers reported holding TURNING POINT THERAPEUTICS I in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $11,686,000 | +109.1% | 155,302 | -25.4% | 0.00% | +200.0% |
| Q1 2022 | $5,588,000 | -43.9% | 208,106 | -0.4% | 0.00% | -50.0% |
| Q4 2021 | $9,968,000 | -31.3% | 208,990 | -4.3% | 0.00% | -33.3% |
| Q3 2021 | $14,514,000 | -6.8% | 218,482 | +9.4% | 0.00% | 0.0% |
| Q2 2021 | $15,580,000 | +4.9% | 199,700 | +27.2% | 0.00% | 0.0% |
| Q1 2021 | $14,847,000 | -28.4% | 156,958 | -7.7% | 0.00% | -40.0% |
| Q4 2020 | $20,727,000 | +55.0% | 170,107 | +11.2% | 0.01% | +66.7% |
| Q3 2020 | $13,369,000 | +70.4% | 153,036 | +26.0% | 0.00% | +50.0% |
| Q2 2020 | $7,847,000 | +68.4% | 121,485 | +16.4% | 0.00% | 0.0% |
| Q1 2020 | $4,661,000 | -27.1% | 104,376 | +1.6% | 0.00% | 0.0% |
| Q4 2019 | $6,397,000 | +263.1% | 102,682 | +119.2% | 0.00% | – |
| Q3 2019 | $1,762,000 | +40.7% | 46,849 | +52.3% | 0.00% | – |
| Q2 2019 | $1,252,000 | – | 30,759 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 308,686 | $13,786,000 | 8.42% |
| Cormorant Asset Management, LP | 3,056,797 | $136,517,000 | 6.34% |
| venBio Partners LLC | 160,333 | $7,160,000 | 6.10% |
| Burrage Capital Management LLC | 77,172 | $3,250,000 | 3.20% |
| Orbimed Advisors | 2,745,327 | $122,606,000 | 2.06% |
| Parkman Healthcare Partners LLC | 80,318 | $3,587,000 | 1.66% |
| SECTORAL ASSET MANAGEMENT INC | 117,800 | $5,261,000 | 1.01% |
| DAFNA Capital Management LLC | 46,908 | $2,095,000 | 0.87% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 35,000 | $1,542,000 | 0.70% |
| Nicholas Investment Partners, LP | 75,487 | $3,371,000 | 0.66% |